• With the generous support of the Nesbitt Charitable Fund we are able to directly fund a study in France of possible environmental causes of PSP, as well as offer support to those patients involved in the study.

  • To participate, call the Janix Call Center at 702-487-0133, and refer to this study by its identifier: NCT02494024. This study is currently not recruiting but please continue to visit our site for updates.

  • Multiple Ascending Dose Study of BMS-986168 in PSP Patients - Recruitment Completed

    This study will evaluate the safety and tolerability of multiple ascending intravenous infusions of BMS-98616, and assess the pharmacodynamics of BMS-986168 on cerebrospinal fluid (CSF) extracellular tau (eTau) concentrations in patients with PSP.

  • The Perelman School of Medicine at the University of Pennsylvania announced today that it has received a grant from the National Institutes of Health's National Institute on Aging to establish the Coordinating Center for Genetics and Genomics of Alzheimer's Disease in collaboration with five other institutions.

  • Dennis W. Dickson, M.D., a neuropathologist at Mayo Clinic's campus in Florida, will receive the highest honor bestowed by the American Association of Neuropathologists (AANP), an international society of physicians and scientists who study, diagnose and treat diseases related to the brain, nerves and muscles. CurePSP supports and partners with the Mayo Clinic Brain Bank.

  • Obscure Disease (PSP) May Offer Backdoor to New Treatments for Alzheimer's and Other Killers